Company news
GuiZhou SanLi Pharmaceutical Co., Ltd. news in 2026
GuiZhou SanLi Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2026, newest first.
(603439)"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Renewal of the Acting-in-Concert Agreement by the Controlling Shareholder and Actual Controller
November 6, 2026
(603439)"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Report for Q3 2026
October 27, 2026
(603439)"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 27th Meeting of the 4th Board of Directors
October 27, 2026
(603439)"GUIZHOU SANLI PHARMACEUTICAL CO., LTD."Announcement on Release of Pledge and Pledge of Certain Shares Held by Controlling Shareholder
October 16, 2026
Announcement on Abnormal Fluctuations in Stock Trading
September 14, 2026
Semi-annual Report for 2026
August 27, 2026
Announcement on Reply to the Shanghai Stock Exchange's Information Disclosure Supervisory Inquiry Letter on the Company's 2025 Annual Report
July 23, 2026
Announcement on Implementation of Repurchase and Cancellation of Restricted Shares under the Equity Incentive Plan
July 21, 2026
Announcement on Expected Decrease in Semi-annual Performance for 2026
July 14, 2026
Announcement on Pledging Partial Shares of Person Acting in Concert of Controlling Shareholder
July 2, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 23, 2026
Announcement on Progress in Drug Marketing Authorization Transfer
June 8, 2026
Announcement on Resolutions of the 24th Meeting of the 4th Board of Directors
May 25, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 20, 2026
Announcement on the Holding of 2026 Collective Reception Day Activities for Investors of Listed Companies in Guizhou Jurisdiction and Outline of the 2025 Annual Performance Briefing
May 12, 2026
Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Guizhou Jurisdiction and 2025 Annual Performance Briefing and Soliciting Questions
April 27, 2026
Announcement on Daily Related Party Transactions in 2025 and Estimates Daily Related Party Transactions in 2026
April 26, 2026
Announcement on Signing the "Agreement on Transfer of Drug Marketing Authorization Holder"
April 1, 2026
Announcement on Repurchasing and Canceling Some Restricted Stocks to Decrease Capital and Notice to Creditors
March 9, 2026
Announcement on Expected Decrease in Performance for 2025
January 23, 2026
Announcement on Resolutions of the 21st Meeting of the 4th Board of Directors
January 8, 2026